CYTX: Management Discusses Increasing Demand for Celution(R) 800 System

By admin | May 11, 2008
Rating 3.00 out of 5
[?]

Submitted By Knobias ClipReport

CYTX: Management Discusses Increasing Demand for Celution(R) 800 System

Cytori Therapeutics, Inc. (CYTX) reported a first quarter loss today of $8.27 million, or $0.34 a share, from $8.67 million, or $0.43 a share, a year earlier. Analysts had expected a loss of $0.36. The Company reported $153,000 in product revenue, the first time it has recognized Celution System-based revenue.

More Here>

Comments

« The real effect of the mortgage crisis on a real person | Home | Market Scan for Small Cap Stocks on May 9, 2008 »